Asia Pacific Automated And Closed Cell Therapy Processing Systems Market Size & Outlook
Related Markets
Asia Pacific automated and closed cell therapy processing systems market highlights
- The Asia Pacific automated and closed cell therapy processing systems market generated a revenue of USD 346.8 million in 2025.
- The market is expected to grow at a CAGR of 22.2% from 2026 to 2033.
- In terms of segment, separation was the largest revenue generating workflow in 2025.
- Separation is the most lucrative workflow segment registering the fastest growth during the forecast period.
- Country-wise, China is expected to register the highest CAGR from 2026 to 2033.
Asia Pacific data book summary
| Market revenue in 2025 | USD 346.8 million |
| Market revenue in 2033 | USD 1,682.6 million |
| Growth rate | 22.2% (CAGR from 2026 to 2033) |
| Largest segment | Separation |
| Fastest growing segment | Separation |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Separation, Expansion, Apheresis, Fill Finish, Cryopreservation |
| Key market players worldwide | Miltenyi Biotec, Lonza Group Ltd, Fresenius SE & Co KGaA, Cytiva, Terumo Corp, Sartorius AG, ThermoGenesis Holdings Inc, Thermo Fisher Scientific Inc, Biospherix, Cellares |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 20.8% of the global automated and closed cell therapy processing systems market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,682.6 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Automated and Closed Cell Therapy Processing Systems Market Scope
Automated and Closed Cell Therapy Processing Systems Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Cellares | View profile | 101-250 | South San Francisco, California, United States, North America | https://www.cellares.com |
| Biospherix | View profile | 101-250 | Parish, New York, United States, North America | http://www.biospherix.com |
| Cytiva | View profile | 10001+ | Marlborough, Massachusetts, United States, North America | https://www.cytivalifesciences.com/en/us |
| Miltenyi Biotec | View profile | 1001-5000 | Bergisch Gladbach, Nordrhein-Westfalen, Germany, Europe | http://www.miltenyibiotec.com |
| Terumo Corp | View profile | 30207 | 2-44-1 Hatagaya, Shibuya-ku, Tokyo, Japan, 151-0072 | https://www.terumo.com |
| Sartorius AG | View profile | 14338 | Otto-Brenner-Strasse 20, Gottingen, NI, Germany, 37079 | https://www.sartorius.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| ThermoGenesis Holdings Inc | View profile | 25 | 2711 Citrus Road, Rancho Cordova, CA, United States, 95742 | https://www.thermogenesis.com |
| Lonza Group Ltd | View profile | 18000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | https://www.lonza.com |
| Fresenius SE & Co KGaA | View profile | 193865 | Else-Kroener-Strasse 1, Bad Homburg, HE, Germany, 61352 | https://www.fresenius.com |
Asia Pacific automated and closed cell therapy processing systems market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to automated and closed cell therapy processing systems market will help companies and investors design strategic landscapes.
Separation was the largest segment with a revenue share of 39.27% in 2025. Horizon Databook has segmented the Asia Pacific automated and closed cell therapy processing systems market based on separation, expansion, apheresis, fill finish, cryopreservation covering the revenue growth of each sub-segment from 2021 to 2033.
Growing government and private investments, increasing healthcare needs, establishment of accelerated approval pathways are key drivers of the Asia Pacific market. Moreover, China is showed as the fast-growing market for cell therapy development.
Favorable regulatory scenario, mature infrastructure for clinical studies, and a booming ecosystem with government–industry collaboration is driving China’s cell and gene therapy development market. In addition, China has been ranked second in term clinical trials across the globe, with over 1,000 clinical trials either completed or ongoing.
Furthermore, Japan is anticipated to witness significant market growth due to rising clinical studies on cell therapies and the rising number of cell therapies advancing from clinical trials to regulatory approval. For instance, in October 2020, Novartis received approval from Japan’s Ministry of Health, Labor, and Welfare for the Foundation for Biomedical Research and Innovation to produce and supply Kymriah in the country.
Reasons to subscribe to Asia Pacific automated and closed cell therapy processing systems market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific automated and closed cell therapy processing systems market databook
-
Our clientele includes a mix of automated and closed cell therapy processing systems market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific automated and closed cell therapy processing systems market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific automated and closed cell therapy processing systems market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific automated closed cell therapy processing systems market report size, by country, 2021-2033 (US$M)
Asia Pacific Automated and Closed Cell Therapy Processing Systems Market Outlook Share, 2025 & 2033 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
